BNET Industries
Market Cap:$1.6B
Last Fiscal Year Sales:$38.9M
- Public
- CA
Dow Jones Description
CryoCath is a medical technology company that leads the world in creating catheter- and probe-based CryoTherapy products to treat cardiovascular disease. Traditionally, the use of freezing temperatures to treat diseased tissue has been limited by the inability to deliver the treatment in a minimally invasive manner. We have successfully overcome this obstacle by developing flexible, steerable, minimally invasive catheters to deliver cold therapy safely and effectively.
Chief Financial Officer
Ginette GagneNumber of Employees 29
Contact Information
16771 Chemin Ste Marie
Montreal, Quebec H9H 5H3
(514) 694-1212
Peer Companies
NAICS Code All Other Business Support Services: 561499
News & Analysis
Filter by
cryocath technologies inc. - All News and Analysis
Cytec Industries Inc. Q3 3009 Earnings Call Transcript
Seeking Alpha
- 2009-10-16
Question-and-Answer SessionOperator Thank you. Operator Instructions. Your first question comes from David Begleiter with Deutsche Bank Securities David Begleiter - Deutsche Bank Securities Shane, given the work you have done in comporting resins, what do you think the normalized margins could be in 2010 and...
Cytec Industries Inc. Q3 2009 Earnings Call Transcript
Seeking Alpha
- 2009-10-16
Question-and-Answer SessionOperator Thank you. Operator Instructions. Your first question comes from David Begleiter with Deutsche Bank Securities David Begleiter - Deutsche Bank Securities Shane, given the work you have done in comporting resins, what do you think the normalized margins could be in 2010 and...
Medtronic Acquires Remaining Shares of CryoCath Technologies Inc
- 2008-12-19
MINNEAPOLIS & MONTREAL -- Medtronic, Inc. (NYSE: MDT) and CryoCath[R] Technologies Inc. (TSX: CYT) announced today that Medtronic has acquired the 1,574,488 shares of CryoCath not already owned by it by exercising its right to compulsorily acquire the CryoCath shares under Section 51 of the Companies Act Quebec. The compulsory...
Medtronic Acquires CryoCath Technologies Inc
- 2008-11-13
MINNEAPOLIS -- Medtronic, Inc. (NYSE:MDT) announced today that it has been successful in its bid, through an indirect wholly-owned subsidiary, to acquire CryoCath[R] Technologies Inc. (TSX:CYT) at $8.75 Cdn per share under its previously announced offer dated October 3, 2008. The offer expired, as scheduled, at 8 p.m. EST on...
Glazer Capital, LLC Acquires Shares of CryoCath Technologies Inc.
- 2008-10-30
Glazer Capital, LLC ("Glazer"), through the funds that it manages, announces that on October 29, 2008 it acquired control of 211,800 common shares of CryoCath Technologies Inc. ("CryoCath") for total consideration of C$1,798,288 (or approximately C$8.49 per common share) representing approximately 0.5% of the issued and outstanding common shares of...
Medtronic buys Canadian device firm CryoCath
- 2008-10-01
In a move to expand its treatment portfolio for heart conditions, including abnormal heart rhythms, Medtronic Inc. is buying Canadian device company CryoCath Technologies. Minneapolis, MN-based Medtronic pay 8.75 Canadian dollars per share, for a total of 400 million Canadian dollars ($380 million), to buy the outstanding shares of...
Medtronic snaps up Canadian firm, CryoCath
- 2008-09-29
Medtronic Snaps Up Canadian Firm, CryoCath. Medtronic Inc. Minneapolis MN, a leader in the stent-making market and a major competitor in the heart device market, announced on Thursday that its was paying 8.75 Canadian dollars ($8.46) for all outstanding shares of CryoCath Technologies Inc. Montreal, which makes devices...
Analyst Reports for Suncor Energy Inc., TriStar Oil & Gas Ltd., Tanganyika Oil Company Ltd. and CryoCath Technologies Inc.
- 2008-09-25
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Suncor...
Medtronic to Acquire CryoCath Technologies Inc
- 2008-09-25
MINNEAPOLIS & MONTREAL -- Medtronic, Inc. (NYSE:MDT) and CryoCath Technologies Inc. (TSX:CYT) today announced they have entered into an agreement whereby Medtronic, through a wholly owned subsidiary, will make a takeover bid for all of the outstanding shares of CryoCath for $8.75 Cdn per share in cash, representing a total...
REMINDER: ORLive Presents: The Cryocath Spotlight Series: Insights and Implications for the Treatment of Atrial Fibrillation
- 2008-06-11
CryoCath® Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, is pleased to report on its participation in Heart Rhythm 2008, the most prominent and comprehensive educational event on heart rhythm disorders . The event was held from May 14 to 17 at the...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Ginette Gagne | Chief Financial Officer |
| Jean-Pierre Desmarais | Chief Scientific Officer |
| Allan Zingeler | Vice President, Global Marketing and Business Development |
| Frank Vandeputte | Vice President, Europe |
| Guy Rodomista | Vice President, Operations |
| Marwan Abboud | Vice President, Technology & Intellectual Property |
| Oliver Bataille | Vice President, Product Dev |
| Olivier Bataille | Vice President, Product Development |
| Robert Mattioli | Vice President, Global Sales |
| Brigitte Speckmaier | Sales Director, Euro |
| Kenneth Ellenbogen | Director-Electrophysiology |
| Mohammad-Reza Jazayeri | Director-Electrophysiology Laboratory |
| Steven Bailin | Director-Electrophysiology |
| Pia Zmuda | Manager, Clinical Practice |
| Ralf Meyer | Manager, EP |
| Georges Archer | Consultant, Industry Expert |
| Paul Montador | Consultant, Industry Expert |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Fredric Milder | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Chief Scientific Officer | Current |
| BioSyntech, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Global Marketing and Business Development | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Europe | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Operations | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Technology & Intellectual Property | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Product Dev | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Product Development | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Vice President, Global Sales | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Sales Director, Euro | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Director-Electrophysiology | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Director-Electrophysiology Laboratory | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Director-Electrophysiology | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Manager, Clinical Practice | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Manager, EP | Current |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Consultant, Industry Expert | Current |
| CryoCath Technologies Inc | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Consultant, Industry Expert | Current |
| CryoCath Technologies Inc | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| CryoCath Technologies Inc | Board of Directors | Current |
| Volume | 298,432 |
| Shares Outstanding | 48.6M |
| Market Cap | 1.6B |
| Year High | 39.57 |
| Year Low | 10.50 |
| Earnings Per Share | -7.65 |
| P/E Ratio | N/A |
| Dividend | 0.050 |
| Yield | 0.144175 |
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS
IndustryTop Rated
